Outcome after depot gonadotrophin-releasing hormone agonist treatment for central precocious puberty: effects on body mass index and final height
Author:
Publisher
Bioscientifica
Subject
Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism
Reference7 articles.
1. Reduction of baseline body mass index under gonadotropin-suppressive therapy in girls with idiopathic precocious puberty
2. Is Obesity an Outcome of Gonadotropin-Releasing Hormone Agonist Administration? Analysis of Growth and Body Composition in 110 Patients with Central Precocious Puberty
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Adding Letrozole to Growth Hormone and Gonadotropin-Releasing Hormone Analog Increases Height in Girls With Short Stature: A Hospital Record–Based Retrospective Study;Endocrine Practice;2024-07
2. Retrospective evaluation of patients diagnosed with central precocious puberty who reached the final height;Journal of Pediatric Endocrinology and Metabolism;2024-06-18
3. Treatment of Central Precocious Puberty with a Focus on Girls;Endocrinology and Metabolism Clinics of North America;2024-06
4. Efficacy and safety of leuprorelin 3-month depot (11.25 mg) for idiopathic central precocious puberty treatment of Chinese girls: a single-center retrospective study;Journal of Pediatric Endocrinology and Metabolism;2023-11-20
5. Adding Letrozole to GH and GnRHa Increase Height in Girls with Short Stature: a hospital record-based retrospective study;2023-10-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3